secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001628280-22-027409
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Neoleukin receives Nasdaq delisting notice for bid price below $1.00
--------------------------------------------------------------------

- Nasdaq notice on Oct 26, 2022 for non-compliance with minimum bid price rule (5550(a)(2)).
- Initial 180-day cure period ends April 24, 2023; needs $1.00+ close for 10 consecutive days.
- May seek transfer to Nasdaq Capital Market for second 180-day grace period if eligible.
- Company evaluating actions but no decisions made; delisting risk remains if not cured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000162828022027409/0001628280-22-027409-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000162828022027409/nltx-20221026.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-027409

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer